Amgen’s got a record of savvy patenting to protect their blockbusters, and they’ve just done it again.
A U.S. Federal District Court in Boston has ruled that Roche’s pegylated-erythropoietin infringes one of Amgen’s patents.
I’m eager to hear the backstory on this one. Amgen previously prevented Transkaryotic (now owned by Shire) from using a completely different [...]
China has overtaken India in an important measure of drug research activity. In an analysis done by the Financial Times, China now has 274 registered clinical trials underway, compared to 260 in Read more…
Original post by admin
Recenly i’ve seen a new SRK movie “chak de india”.the movie is too good and a must watch movie.though i dont like SRK but he is too good in this film as a hockey coach.he has done a very natural job in this film..the film is directed by shimin amin.this is his second film [...]
The FDA approved 38 drugs through July this year, down 31 percent from 55 approvals for the same period last year.
Who’s to blame? According to Friedman, Billings, Ramsey, the FDA. Why? Vioxx.
For details on extra scrutiny being applied by the FDA, see this CNNMoney summary.
Original post by BiotechBlog
Welcome to the second August 2007 edition of Carnival of Biotechnology.
International Biotechnology
The Times (UK) has a report on the UK biotech sector, calling for consolidation to overcome a lack of capital.
The Wall Street Journal has an article on Novartis’ lost patent case in India, where a patent on an improved version of Glivec (sold as [...]
